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Abstract
I In nt tr ro od du uc ct ti io on n: :    The  PROSPECT  trial  reported  no  single  echocardiographic
measurement of dyssynchrony is recommended to improve patient selection
for cardiac resynchronization therapy (CRT). 
M Ma at te er ri ia al l   a an nd d   m me et th ho od ds s: :   In 100 consecutive patients who received CRT, we
analyzed 27 ECG and echocardiographic variables to predict a positive response
to CRT defined as a left ventricular (LV) end systolic volume decrease of ≥ 15%
after CRT.
R Re es su ul lt ts s: :   Right ventricular (RV) pacing-induced left bundle branch block (LBBB),
time difference between LV ejection measured by tissue Doppler and pulsed
wave Doppler (TTDI-PW), and wall motion score index (WMSI) were significantly
associated with positive CRT response by multivariate regression. We assigned
1 point for RV pacing-induced LBBB, 1 point for WMSI ≤ 1.59, and 2 points for
TTDI-PW > 50 ms. Overall mean response score was 1.79 ±1.39. Cutoff point for
response score to predict positive response to CRT was > 2 by receiver operating
characteristic (ROC) analysis. Area under ROC curve was 0.97 (p = 0.0001).
Cardiac resynchronization therapy responders in patients with response score
> 2 and ≤ 2 were 36/38 (95%) and 7/62 (11%, p < 0.001), respectively. After age
and gender adjustment, the response score was related to CRT response (OR =
45.4, p < 0.0001). 
C Co on nc cl lu us si io on ns s: :   A response score generated from clinical, ECG and echo  cardio  -
graphic variables may be a useful predictor for CRT response. However, this
needs to be validated.
K Ke ey y   w wo or rd ds s: :   cardiac resynchronization therapy, wall motion score index.
Introduction
Cardiac resynchronization therapy (CRT) improves cardiac performance
for patients who have severe congestive heart failure and a wide QRS
complex [1-3]. However, patient response to CRT is not homogeneous.
Cardiac function is not improved in approximately 30% of patients with
a wide QRS who received CRT according to the criteria of the present
guidelines [3]. It is also unclear as to which patient profiles will benefit the
most from CRT. Cardiac resynchronization therapy is an invasive therapy
and associated with a median incremental cost of $107,800 (interquartile
range, $79,800 to $156,500) per additional quality-adjusted life year (QALY).
Cardiac resynchronization therapy should be avoided in patients in which
there is no benefit [4]. 
C Co or rr re es sp po on nd di in ng g   a au ut th ho or r: :
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The Predictors of Response to CRT (PROSPECT)
trial reported that no single echocardiographic
measurement of dyssynchrony may be recom  -
mended to improve patient selection for CRT [5].
We hypothesized that CRT response is not only
related  to  left  ventricular  (LV)  mechanical
dyssynchrony (LVMD), but is also related to other
variables such as right ventricular (RV) pacing-
induced left bundle branch block (LBBB) [6, 7], 
LV segmental wall motion score index (WMSI) [8],
LV restrictive filling (LVRF) [9], mitral regurgitation
(MR) [3], and left atrial volume [10]. We further
hypothesized that a response score based on the
above factors may be helpful in improving our
ability to predict CRT response.
Material and methods
We retrospectively evaluated 147 consecutive
patients  who  received  CRT  at  the  Creighton
University Medical Center for potential participation
in the study. The criteria for biventricular pacemaker
implantation  followed  American  College  of
Cardiology/American Heart Association guidelines
[11]. The QRS duration in all patients was measured
from surface electrocardiograms using the widest
QRS complex in leads II, V1, and V6. Forty-seven
patients were excluded because of atrial fibrillation,
mitral stenosis, or loss to follow-up. The remaining
100 patients (73 men and 27 women, mean age 70
±10 years) were included in the study. Of the 
100 pa  tients, 66 (66%) had ischemic heart disease, 
26 (26%), had 3-vessel coronary artery disease, 
32  (32%)  had  previous  myocardial  infarction, 
75 (75%) had intrinsic LBBB, and 25 (25%) had RV
pacing-induced LBBB (pacemaker-dependent right
ventricular  pacing  for  at  least  6  months,  and 
an upgrade of RV pacemaker or implantable cardio  -
verter-defibrillator  to  CRT).  All  100  patients
underwent coronary angiography before CRT.
After informed written consent was obtained, all
patients underwent implantation of a biventricular
pacer in the cardiac electrophysiology laboratory.
The lead was positioned into the left the lateral LV
vein. After the pacing and sensing parameters were
measured, the LV pacing lead was secured with
a supporting style. The RV defibrillation lead was
screwed into the RV apex. The atrial pacing lead
was screwed into the high lateral right atrium. The
results depended on the endocardial lead position. 
Conventional transthoracic echocardiography
was  performed  with  the  Philips  Sonos  7500
echocardiographic system and a s3 transducer.
Baseline echocardiographic data before CRT and
the post CRT follow-up echocardiograms were
reviewed for all patients. Left ventricular end-
systolic volume, LV end-diastolic volume, LV ejection
fraction, and left atrial volume were measured in
the  apical  view  from  the  videotape  or  Philips
Enconcert digital system according to the standard
recommended by American Society of Echocardio  -
graphy [12]. Left ventricular end-systolic and end-
diastolic  dimensions  were  measured  in  the
parasternal long-axis view. A positive response to
CRT was defined as a LV end systolic volume
decreasing ≥ 15% after CRT [13].
Left ventricular mechanical dyssynchrony was
evaluated by Pérez’s method by combined pulsed
wave Doppler and tissue Doppler [14, 15]. The time
difference (TPW-TDI) between the onset of Q wave
to the end of the systolic wave in the basal lateral
or septal segments with the greatest contraction
delay assessed by tissue Doppler imaging (TDI)
(TTDI) and the onset of Q wave to the end of LV
ejection assessed by pulsed wave Doppler (PW)
(TPW) was measured within one month before CRT
(Figure 1). TPW-TDI > 50 ms was defined as LVMD [14,
15]. Pulsed TDI was only used in this study. Color
TDI was not used.
The  motion  of  individual  LV  segments  was
graded as follows: normal = 1, hypokinesia = 2,
akinesia  =  3,  and  dyskinesia  =  4.  The  WMSI 
was  analyzed  using  a 17  segment  model  and
calculated by the total score/number of segments
analyzed [12]. 
Left ventricular filling was evaluated by PW and
TDI  and  classified  into  4  patterns:  1)  normal, 
2) LV relaxation abnormality, 3) pseudo-norma  -
lization, and 4) LVRF. 
The severity of MR was classified into 3 grades:
mild, moderate, and severe by the color flow jet
area as recommended by guidelines from the
American Society of Echocardiography [16]. A color
flow jet area < 40% and > 20% of left atrial area
was defined as moderate, and moderate or severe
MR was defined as significant MR.
The  variables  used  for  analysis  are  listed  in 
Table I [17]. Continuous variables were presented as
a mean ±1 standard deviation and were compared
using analysis of variance. Categorical data were
assessed with a ˇ2 or by a Fisher-exact test if 
the  cell  sizes  were  <  5.  A receiver  operating
characteristic (ROC) curve was used for evaluation
of the cutoff value, sensitivity and specificity of the
parameter to predict a positive response to CRT. The
area under the ROC curve (AUC) was used for
comparison between the scoring system and LVMD
in evaluation of CRT response. We evaluated the
relative variables to CRT response by multivariate
logistic regression model using SPSS version 16.0
software. Each variable was evaluated by a forward
selection method to select variables for multivariate
regression  based  on  the  calculated  score  ˇ2
statistic. The variable with the largest score ˇ2
statistics was added to the model. For each selected
variable, the logistic procedure then calculated the
point estimate of odds ratio, Wald statistics, 95%Arch Med Sci 4, August / 2011 629
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Wald  confidence  limits  and  p value.  Cardiac
resynchronization therapy response score was
generated by the variables with a significant level
of p < 0.05 by multivariate regression. We assigned
1 point for the variables achieving a significance
level by multivariate regression. The Wald test was
used to evaluate the weight of the variables in
order to predict CRT response [18]. We assigned 
2 points for the variable with the highest value of
Wald. Higher scores represented a higher positive
response to CRT. A p value of < 0.05 was considered
statistically significant.
The study was approved by the Institutional
Review Board of Creighton University School of
Medicine.
Results
The implantation procedure was successfully
performed in all 100 patients. The LV capture
threshold was 1.85 ±1.06 volts, and the mean LV
pacing impedance was 1,005 ±355 ohms. Of the 100
patients, 75 (75%%) had intrinsic LBBB, and 25
(25%) had RV pacing-induced LBBB. The follow-up
duration after CRT was 17.0 ±10.6 months. Forty-
three patients (43%) were defined as positive CRT
responders. There was no significant difference in
follow-up duration between CRT responders (16.6
±11.1  months)  and  non-responders  (17.4  ±10.3
months, p = 0.72). 
There were 43 patients with LVRF and 40 patients
with MR ≥ moderate. The ECG and echocardio  -
graphic measurements before andat the end of
follow-up after CRT are listed in Table II. There were
significant differences in LVEF and TTDI-PW during
follow-up  of  14.39  ±10.5  months  after  CRT
compared to baseline (p = 0.0001 and p < 0.0001).
The cutoff point for WMSI to predict negative
response to CRT was > 1.59 by ROC analysis. 
All study patients were treated with optimal
medical therapy. Of 100 patients, 90 (90%) were on
a ʲ-blocker, 88 (88%) were on an angiotensin
converting enzyme inhibitor or an angiotensin
receptor blocker, 55 (55%) were on loop diuretics,
35 (35%) were on spironolactone, 29 (29%) were on
loop diuretics and spironolactone, and 72 (72%)
were on digoxin.
Table III lists the results of multivariate regression
for evaluation of the variables which achieved 
the largest score ˇ2 statistics when the dependent
variable  was  a positive  response  to  CRT. 
The variables of RV pacing-induced LBBB [odds 
ratio (OR) = 12.13, p = 0.005], TTDI-PW (OR = 1.06, 
p <  0.0001)  and  WMSI  (OR  =  0.18,  p =  0.03)
achieved a significant level of p < 0.05. The TTDI-PW
was associated with the highest value of Wald
(wald value = 19.74) compared to the variables of
RV pacing-induced LBBB and WMSI (wald value =
7.71 and 4.87).
A 4-point score system was generated based on
3 variables: 1) RV pacing-induced LBBB, 2) TTDI-PW
and 3) WMSI that achieved a significant level of 
p < 0.05 to a positive CRT response analyzed by
multivariate regression. We assigned 1 point for RV
pacing-induced LBBB, 1 point for WMSI ≤ 1.59, and
2 points for TTDI-PW > 50 ms (Wald value was the
highest  compared  to  others).  Higher  scores
represent a better chance for a positive response
to CRT. The overall mean response score was 1.79
±1.39 (0-4). The cutoff point for a response score to
predict positive response to CRT was > 2 by ROC
or –
TTDI
LVMD = TTDI – TPW, if TTDI – TPW > 50 ms
TPW
F Fi ig gu ur re e   1 1. . The calculation for LVMD is shown. Left ventricular mechanical dyssynchrony was defined as the difference
between TTDI and TPW if the difference was more than 50 ms
LVMD – left ventricular mechanical dyssynchrony, TTDI – the onset of Q wave to the end of the systolic wave in the basal lateral or
septal segments with the greatest contraction delay, TPW  – The onset of Q wave to the end of left ventricular ejection630 Arch Med Sci 4, August / 2011
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analysis. The area under the ROC curve (AUC) was
0.97 (95% CI 0.92-0.99, SE = 0.02, p = 0.0001)
(Figure  2).  The  sensitivity  and  specificity  for
prediction  of  a positive  response  to  CRT  at
a response  score  >  2  were  83.7%  and  96.5%,
respectively. Cardiac resynchronization therapy
responders in patients with a response score > 2
and ≤ 2 were 36/38 (95%) and 7/62 (11%, p < 0.001),
respectively. After adjustment for age (OR = 1.03, 
p =  0.54)  and  gender  (OR  =  0.13,  p  =  0.06), 
the response score was related to CRT response 
(OR = 45.4, p < 0.0001) by multivariate regression.
The  response  score  >  2  was  associated  with 
a 45-fold  increase  in  predicting  CRT  response
compared to a response score ≤ 2.
The overall mean TTDI-PW was 74.67 ±48.53 ms.
The cutoff point for TTDI-PW to predict a positive
response to CRT was > 50 ms by ROC analysis. The
area  under  the  ROC  curve  (AUC)  was  0.92 
(p = 0.0001). The sensitivity and specificity for
prediction of a positive response to CRT at the
cutoff  point  >  50  ms  were  98%  and  80.7%,
respectively. The area under the ROC curve and
specificity for the response score to predict a CRT
response  were  significantly  higher  compared 
to TTDI-PW (AUC = 0.97 vs. 0.92, p = 0.0001; spe  -
cificity = 96.5% vs. 80.7%). 
Discussion
The  PROSPECT  trial  reported  that  no  single
echocardiographic  measurement  of  ventricular
dyssynchrony may be recommended to improve
patient selection for CRT [5]. Mechanical dysynchrony
measures are not in any guidelines for selection of
patients for CRT. We generated a new response score
system to predict CRT response before biventricular
pacemaker implantation based on: 1) RV pacing-
induced LBBB, 2) WMSI and 3) TTDI-PW. The score
system not only considered the effect of ventricular
dyssynchrony, but also considered the effects of the
LBBB pattern and LV wall motion abnormality in
patients with and without coronary artery disease.
The response score > cutoff point was associated
with a 45-fold increase in predicting CRT response.
The area under the ROC curve and specificity for
response  score  to  predict  CRT  response  were
Age
Gender
QRS duration
QRS morphology divided into: 
a) left bundle branch block  
b) intraventricular conduction disease  
c) paced rhythm and 
d) right bundle branch block
Ischemic heart disease (coronary stenosis ≥ 70% reduction 
in luminal diameter)
Hypertension
Diabetes mellitus
Intrinsic or right ventricular pacing-induced left bundle 
branch block 
Left ventricular capture threshold 
Left ventricular pacing impedance
TTDI-PW : the time difference between the onset of Q wave 
to the end of the systolic wave in the basal lateral or septal 
segments with the greatest contraction delay assessed by 
tissue Doppler imaging and the onset of Q wave to the 
end of left ventricular ejection assessed by pulsed wave 
Doppler
Left ventricular restrictive filling 
Wall motion score index 
Left ventricular end-diastolic dimension
Left ventricular end-systolic dimension
Left ventricular hypertrophy, defined as left ventricular 
wall thickness > 11 mm
Left ventricular ejection fraction 
Left atrial volume index 
Significant mitral regurgitation
Mitral regurgitation degree
ʲ-Blockers
Angiotensin-converting enzyme inhibitors or angiotensin 
receptor blockers 
Loop diuretics
Spironolactone
Loop diuretics and spironolactone
Digoxin
New York Heart Association class
T Ta ab bl le e   I I. . Variables used in the analysis
P Pa ar ra am me et te er r A At t   b ba as se el li in ne e A At t   e en nd d   o of f    V Va al lu ue e   o of f   p p
f fo ol ll lo ow w- -u up p
QRS duration [ms] 165.4 ±27.9 157.7 ±29.4 0.06
LVDd [mm] 64.6 ±10.5 61.8 ±11.1 0.08
LVDs [mm] 53.7 ±11.5 52.4 ±12.3 0.43
LVVs [ml] 174.0 ±76.0 156.6 ±74.3 0.10
LVEF (%) 20.4 ±6.6 25.8 ±12.2 0.0001
LAVI [ml/m2] 59.9 ±22.7 57.0 ±19.3 0.32
TTDI-PW [ms] 74.7 ±48.5 48.4 ±31.6 < 0.001
T Ta ab bl le e   I II I. .   QRS duration and echocardiographic mea  -
sure  ments at baseline and at end of follow-up after
cardiac resynchronization therapy
LVDd – left ventricular dimension in end-diastole, LVDs – left ventricular
dimension in end-systole, LVVs – left ventricular volume in end-systole,
LVEF – left ventricular ejection fraction, LAVI – left atrial volume indexArch Med Sci 4, August / 2011 631
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significantly higher compared to TTDI-PW (AUC = 0.97
vs. 0.92, p = 0.0001; specificity = 96.5% vs. 80.7%).
Heist et al. [19] described a response score to
predict both hemodynamic and clinical outcomes
from CRT. A 4-point response score was generated
using variables associated with ∆dP/dt by Doppler
echocardiography, the dorsoventral LV/RV inter-lead
distance by lateral chest radiography, the LV lead
electrical delay by ECG, and the maximum time
difference to peak systolic velocity by TDI. They
found that there was a significant association
between response score (0-4 points) and acute
hemodynamic  response  to  CRT  (p <  0.0001).
However, the point for a dorsoventral LV/RV inter-
lead distance and the point for a LV lead electrical
delay needed to be measured after implantation
and  during  the  procedure  of  biventricular
pacemaker implantation. Therefore, the response
score was unable to establish a pre-implantation
predictor to predict the lack of benefit after CRT.
Furthermore, the method for evaluation of the
response score neglected the effects of ischemic
heart disease on the CRT response.
Our previous study showed that patients with
heart failure and RV pacing-induced LBBB had
a better response rate to CRT when compared to
patients with intrinsic LBBB [6]. The percentage of
CRT responders in patients with RV pacing-induced
LBBB was significantly greater than in patients with
intrinsic LBBB (p = 0.04) and was associated with
a greater decrease of QRS duration (p = 0.01). This
finding is consistent with the data from the Dual
Chamber and VVI Implantable Defibrillator (DAVID)
trial [20, 21]. One hypothesis is that RV pacing-
induced LBBB is truly dissimilar to intrinsic LBBB
[22]. However, the upper value of 95% CI for odds
ratio in RV pacing-induced LBBB was high (70.67).
This suggested that the sample size of RV pacing-
induced  LBBB  was  small  for  predicting  CRT
response, and that the result may be inaccurate.
Further prospective studies using large number of
patients appear warranted.
The study demonstrated that higher WMSI had
a poorer response to CRT. High WMSI was a result of
prior myocardial infarction in patients with ischemic
heart disease and myocardial fibrosis in patients with
non-ischemic heart disease [8, 23]. Wall motion
abnormalities can affect intraven  tricular conduction
and the coordinated mechanical response of the
ventricles. Cardiac resynchronization therapy may
correct  conduction  delay  in  remodeled  dilated
myocardial segments, but has no effect on extensive
myocardial scars or ischemic segments [24].
W Wa al ld d O Od dd ds s   r ra at ti io o V Va al lu ue e   o of f   p p 9 95 5% %   C CI I   f fo or r   o od dd ds s   r ra at ti io o
L Lo ow we er r U Up pp pe er r
G Ge en nd de er r 3.47 0.15 0.06 0.02 1.11
Q QR RS S   d du ur ra at ti io on n 2.62 1.02 0.11 1.00 1.05
N Ne ew w   Y Yo or rk k   H He ea ar rt t   A As ss so oc ci ia at ti io on n   c cl la as ss s 0.11 1.33 0.74 0.24 7.39
I Is sc ch he em mi ic c   h he ea ar rt t   d di is se ea as se e 0.48 2.22 0.49 0.23 21.18
R RV V   p pa ac ci in ng g- -i in nd du uc ce ed d   L LB BB BB B 7.71 12.13 0.005 2.08 70.67
T TT TD DI I- -P PW W 19.74 1.06 < 0.0001 1.04 1.09
W Wa al ll l   m mo ot ti io on n   s sc co or re e   i in nd de ex x 4.87 0.19 0.03 0.04 0.83
ʲ ʲ- -B Bl lo oc ck ke er rs s 1.55 0.23 0.21 0.02 2.30
L Lo oo op p   d di iu ur re et ti ic cs s 0.01 0.88 0.91 0.10 8.02
S Sp pi ir ro on no ol la ac ct to on ne e 1.62 0.20 0.20 0.02 2.40
T Ta ab bl le e   I II II I. . Results of multivariate regression for evaluation of 10 variables when the dependent variable was a positive
response to cardiac resynchronization therapy
RV – right ventricular, LBBB – left bundle branch block
100
80
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0
0 20 40 60 80 100
1 10 00 0- -S Sp pe ec ci if fi ic ci it ty y
Sensitivity: 83.7
Specificity: 96.5
Criterion: > 2
F Fi ig gu ur re e   2 2. .   The area under the ROC curve (AUC) was
0.97 (95% CI 0.92-0.99, SE = 0.02, p = 0.0001)
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We selected Pérez’s method to determine LVMD
in order to measure time intervals of LV ejection by
combined tissue Doppler imaging and pulsed wave
Doppler [14, 15]. The time derived by pulsed wave
Doppler represented the mean time interval of LV
ejection, while the time derived by tissue Doppler
represented segmental time delay of LV ejection.
This  method  provides  reliable  and  accurate
measurements in determining LVMD [14, 15]. It also
better defines the endpoint of LV flow and motion
velocity spectrum by pulsed wave Doppler and
tissue Doppler than the method that defines the
endpoint of peak systolic velocity only from a tissue
Doppler spectrum because of the blunt nature of
the peak velocity profile and double peaks [25].
The detection rate of LVMD is lower in patients
with heart failure and wide QRS duration both in
Pérez’s study (39.4%) [14, 15] and in our current
study (43%), compared to other studies (60-75%)
[26]. The cause of lower CRT response rate may be
related to ischemic heart disease. In our study, 66%
of patients had ischemic heart disease with ≥ 70%
coronary artery narrowing, 26% of patients had 
3-vessel  coronary  artery  disease,  and  32%  of
patients had previous myocardial infarction. These
data are consistent with previous studies that
suggested CRT may be less beneficial among heart
failure  patients  with  ischemic  heart  disease
compared to non-ischemic heart disease [24, 27-
29]. However, ischemic heart disease was shown
not to be predictive of CRT response in multivariate
regression analysis possibly due to a small number
of patients with high upper 95% CI (21.2). The
cardiac performance may also be affected by the
longer follow-up duration in our study compared to
typical CRT response studies [26]. 
This is a single center retrospective study with
a relatively small number of patients who received
CRT. Our results should only be applied to patients
with sinus rhythm because our study population
did not include patients with atrial fibrillation.
Although the follow-up duration in this study was
not constant for each patiernt after CRT, there was
no significant difference in follow-up duration
between CRT responders and non-responders. This
scoring system has not been tested prospectively
to determine its utility in a large number of patients
receiving CRT. 
In conclusion, a response score generated from
clinical, ECG and echocardiographic variables may
be a useful predictor for CRT response. However,
this score needs to be validated prospectively in
a large number of patients receiving CRT.
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